Putting the brakes on mammary tumorigenesis: Loss of STAT1 predisposes to intraepithelial neoplasias

Christine Schneckenleithner, Zsuzsanna Bago-Horvath, Helmut Dolznig, Nina Neugebauer, Karoline Kollmann, Thomas Kolbe, Thomas Decker, Dontscho Kerjaschki, Kay-Uwe Wagner, Mathias Müller, Dagmar Stoiber, Veronika Sexl

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Multiparous Stat1-/- mice spontaneously develop mammary tumors with increased incidence: at an average age of 12 months, 55% of the animals suffer from mammary cancer, although the histopathology is heterogeneous. We consistently observed mosaic expression or down-regulation of STAT1 protein in wild-type mammary cancer evolving in the control group. Transplantation experiments show that tumorigenesis in Stat1-/- mice is partially influenced by impaired CTL mediated tumor surveillance. Additionally, STAT1 exerts an intrinsic tumor suppressing role by controlling and blocking proliferation of the mammary epithelium. Loss of STAT1 in epithelial cells enhances cell growth in both transformed and primary cells. The increased proliferative capacity leads to the loss of structured acini formation in 3D-cultures. Analogous effects were observed when Irf1-/- epithelial cells were used. Accordingly, the rate of mammary intraepithelial neoplasias (MINs) is increased in Stat1-/- animals: MINs represent the first step towards mammary tumors. The experiments characterize STAT1/IRF1 as a key growth inhibitory and tumor suppressive signaling pathway that prevents mammary cancer formation by maintaining growth control. Furthermore, they define the loss of STAT1 as a predisposing event via enhanced MIN formation.

Original languageEnglish (US)
Pages (from-to)1043-1054
Number of pages12
JournalOncotarget
Volume2
Issue number12
DOIs
StatePublished - Jan 1 2011

Fingerprint

Carcinogenesis
Breast
Breast Neoplasms
Neoplasms
Growth
Epithelial Cells
STAT1 Transcription Factor
Down-Regulation
Epithelium
Transplantation
Control Groups
Incidence

Keywords

  • IRF1
  • MIN
  • Mammary cancer
  • Stat1
  • Tumorsurveillance

ASJC Scopus subject areas

  • Oncology

Cite this

Schneckenleithner, C., Bago-Horvath, Z., Dolznig, H., Neugebauer, N., Kollmann, K., Kolbe, T., ... Sexl, V. (2011). Putting the brakes on mammary tumorigenesis: Loss of STAT1 predisposes to intraepithelial neoplasias. Oncotarget, 2(12), 1043-1054. https://doi.org/10.18632/oncotarget.371

Putting the brakes on mammary tumorigenesis : Loss of STAT1 predisposes to intraepithelial neoplasias. / Schneckenleithner, Christine; Bago-Horvath, Zsuzsanna; Dolznig, Helmut; Neugebauer, Nina; Kollmann, Karoline; Kolbe, Thomas; Decker, Thomas; Kerjaschki, Dontscho; Wagner, Kay-Uwe; Müller, Mathias; Stoiber, Dagmar; Sexl, Veronika.

In: Oncotarget, Vol. 2, No. 12, 01.01.2011, p. 1043-1054.

Research output: Contribution to journalArticle

Schneckenleithner, C, Bago-Horvath, Z, Dolznig, H, Neugebauer, N, Kollmann, K, Kolbe, T, Decker, T, Kerjaschki, D, Wagner, K-U, Müller, M, Stoiber, D & Sexl, V 2011, 'Putting the brakes on mammary tumorigenesis: Loss of STAT1 predisposes to intraepithelial neoplasias', Oncotarget, vol. 2, no. 12, pp. 1043-1054. https://doi.org/10.18632/oncotarget.371
Schneckenleithner C, Bago-Horvath Z, Dolznig H, Neugebauer N, Kollmann K, Kolbe T et al. Putting the brakes on mammary tumorigenesis: Loss of STAT1 predisposes to intraepithelial neoplasias. Oncotarget. 2011 Jan 1;2(12):1043-1054. https://doi.org/10.18632/oncotarget.371
Schneckenleithner, Christine ; Bago-Horvath, Zsuzsanna ; Dolznig, Helmut ; Neugebauer, Nina ; Kollmann, Karoline ; Kolbe, Thomas ; Decker, Thomas ; Kerjaschki, Dontscho ; Wagner, Kay-Uwe ; Müller, Mathias ; Stoiber, Dagmar ; Sexl, Veronika. / Putting the brakes on mammary tumorigenesis : Loss of STAT1 predisposes to intraepithelial neoplasias. In: Oncotarget. 2011 ; Vol. 2, No. 12. pp. 1043-1054.
@article{55e203aece02439ebc8525f32069c0bc,
title = "Putting the brakes on mammary tumorigenesis: Loss of STAT1 predisposes to intraepithelial neoplasias",
abstract = "Multiparous Stat1-/- mice spontaneously develop mammary tumors with increased incidence: at an average age of 12 months, 55{\%} of the animals suffer from mammary cancer, although the histopathology is heterogeneous. We consistently observed mosaic expression or down-regulation of STAT1 protein in wild-type mammary cancer evolving in the control group. Transplantation experiments show that tumorigenesis in Stat1-/- mice is partially influenced by impaired CTL mediated tumor surveillance. Additionally, STAT1 exerts an intrinsic tumor suppressing role by controlling and blocking proliferation of the mammary epithelium. Loss of STAT1 in epithelial cells enhances cell growth in both transformed and primary cells. The increased proliferative capacity leads to the loss of structured acini formation in 3D-cultures. Analogous effects were observed when Irf1-/- epithelial cells were used. Accordingly, the rate of mammary intraepithelial neoplasias (MINs) is increased in Stat1-/- animals: MINs represent the first step towards mammary tumors. The experiments characterize STAT1/IRF1 as a key growth inhibitory and tumor suppressive signaling pathway that prevents mammary cancer formation by maintaining growth control. Furthermore, they define the loss of STAT1 as a predisposing event via enhanced MIN formation.",
keywords = "IRF1, MIN, Mammary cancer, Stat1, Tumorsurveillance",
author = "Christine Schneckenleithner and Zsuzsanna Bago-Horvath and Helmut Dolznig and Nina Neugebauer and Karoline Kollmann and Thomas Kolbe and Thomas Decker and Dontscho Kerjaschki and Kay-Uwe Wagner and Mathias M{\"u}ller and Dagmar Stoiber and Veronika Sexl",
year = "2011",
month = "1",
day = "1",
doi = "10.18632/oncotarget.371",
language = "English (US)",
volume = "2",
pages = "1043--1054",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "12",

}

TY - JOUR

T1 - Putting the brakes on mammary tumorigenesis

T2 - Loss of STAT1 predisposes to intraepithelial neoplasias

AU - Schneckenleithner, Christine

AU - Bago-Horvath, Zsuzsanna

AU - Dolznig, Helmut

AU - Neugebauer, Nina

AU - Kollmann, Karoline

AU - Kolbe, Thomas

AU - Decker, Thomas

AU - Kerjaschki, Dontscho

AU - Wagner, Kay-Uwe

AU - Müller, Mathias

AU - Stoiber, Dagmar

AU - Sexl, Veronika

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Multiparous Stat1-/- mice spontaneously develop mammary tumors with increased incidence: at an average age of 12 months, 55% of the animals suffer from mammary cancer, although the histopathology is heterogeneous. We consistently observed mosaic expression or down-regulation of STAT1 protein in wild-type mammary cancer evolving in the control group. Transplantation experiments show that tumorigenesis in Stat1-/- mice is partially influenced by impaired CTL mediated tumor surveillance. Additionally, STAT1 exerts an intrinsic tumor suppressing role by controlling and blocking proliferation of the mammary epithelium. Loss of STAT1 in epithelial cells enhances cell growth in both transformed and primary cells. The increased proliferative capacity leads to the loss of structured acini formation in 3D-cultures. Analogous effects were observed when Irf1-/- epithelial cells were used. Accordingly, the rate of mammary intraepithelial neoplasias (MINs) is increased in Stat1-/- animals: MINs represent the first step towards mammary tumors. The experiments characterize STAT1/IRF1 as a key growth inhibitory and tumor suppressive signaling pathway that prevents mammary cancer formation by maintaining growth control. Furthermore, they define the loss of STAT1 as a predisposing event via enhanced MIN formation.

AB - Multiparous Stat1-/- mice spontaneously develop mammary tumors with increased incidence: at an average age of 12 months, 55% of the animals suffer from mammary cancer, although the histopathology is heterogeneous. We consistently observed mosaic expression or down-regulation of STAT1 protein in wild-type mammary cancer evolving in the control group. Transplantation experiments show that tumorigenesis in Stat1-/- mice is partially influenced by impaired CTL mediated tumor surveillance. Additionally, STAT1 exerts an intrinsic tumor suppressing role by controlling and blocking proliferation of the mammary epithelium. Loss of STAT1 in epithelial cells enhances cell growth in both transformed and primary cells. The increased proliferative capacity leads to the loss of structured acini formation in 3D-cultures. Analogous effects were observed when Irf1-/- epithelial cells were used. Accordingly, the rate of mammary intraepithelial neoplasias (MINs) is increased in Stat1-/- animals: MINs represent the first step towards mammary tumors. The experiments characterize STAT1/IRF1 as a key growth inhibitory and tumor suppressive signaling pathway that prevents mammary cancer formation by maintaining growth control. Furthermore, they define the loss of STAT1 as a predisposing event via enhanced MIN formation.

KW - IRF1

KW - MIN

KW - Mammary cancer

KW - Stat1

KW - Tumorsurveillance

UR - http://www.scopus.com/inward/record.url?scp=84862980088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862980088&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.371

DO - 10.18632/oncotarget.371

M3 - Article

C2 - 22185785

AN - SCOPUS:84862980088

VL - 2

SP - 1043

EP - 1054

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 12

ER -